Metabolite: HMDB0000588 (Sodium)
Term: Esmolol Action Pathway
Definition: because it predominantly blocks the beta-1 receptors in cardiac tissue, it is said to be cardioselective. in general, so-called cardioselective beta-blockers are relatively cardioselective; at lower doses they block beta-1 receptors only but begin to block beta-2 receptors as the dose increases.
Parent Term: Biochemical pathway
Parent Definition: A linked series of chemical reactions that occur in a defined order within or between organism cells, and lead to a known function or end product.
Other Metabolites Mapped to 'Esmolol Action Pathway'